A Durham-based biopharmaceutical company says it has gotten the okay from the Food and Drug Administration to test its experimental cancer drug on COVID-19 patients in the U.S. The company, Chimerix, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback